Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Deferred financing costs	$ 8,898	$ 3,911
Common shares, par value	$ 0.001	$ 0.001
Common shares, issued	40,712,963	21,882,028
Common shares, outstanding	40,712,963	21,882,028
Non-controlled, Non-affiliated Investments
Investments at amortized cost	$ 2,007,948	$ 809,029